The CBER is the center in the FDA responsible for the following:

• Acceptance and review of an investigational new drug application (INDA) prior to initiating a clinical trial;



• Establishment inspection;



• Review and issuance of a biologics license;



• Post-marketing surveillance of approved biologics.